Zosano Pharma Corp.
(NASDAQ : ZSAN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
INOInovio Pharmaceuticals, Inc. 10.93%25.946.3%$1455.01m
TMOThermo Fisher Scientific, Inc. 1.93%389.941.0%$566.30m
MDTMedtronic Plc 2.85%93.400.6%$538.13m
DXCMDexCom, Inc. -0.95%435.488.2%$520.73m
ABTAbbott Laboratories 2.58%95.440.8%$507.67m
BDXBecton, Dickinson & Co. 1.21%260.491.0%$501.46m
DHRDanaher Corp. 1.07%185.640.7%$451.39m
BSXBoston Scientific Corp. 0.94%35.011.0%$433.53m
QDELQuidel Corp. 2.38%252.517.7%$421.93m
ISRGIntuitive Surgical, Inc. 2.10%587.982.4%$340.98m
SYKStryker Corp. 1.06%179.771.3%$311.81m
BAXBaxter International, Inc. 0.09%85.311.8%$275.88m
ALGNAlign Technology, Inc. 1.30%276.846.4%$227.20m
ZBHZimmer Biomet Holdings, Inc. 2.34%122.221.7%$210.09m
BIOBio-Rad Laboratories, Inc. 1.25%483.632.9%$201.57m

Company Profile

Zosano Pharma Corp. is a clinical stage biopharmaceutical company, which engages in the development of human pharmaceutical products. The firm focuses on providing rapid systemic administration of therapeutics to patients using proprietary intracutaneous microneedle system. It offers Qtrypta, a formulation of zolmitriptan delivered utilizing the intracutaneous microneedle system. The company was founded in October 2006 and is headquartered in Fremont, CA.